ANGELA BROWN: Open Payments
NPI 1548225584 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 35 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,248
Food & beverage: $1,169Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $283 |
| Alkermes, Inc. | 5 | $228 |
| Teva Pharmaceuticals USA, Inc. | 4 | $153 |
| E.R. Squibb & Sons, L.L.C. | 5 | $137 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Braeburn Inc. | 1 | $122 |
| ABBVIE INC. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: SPRAVATO, LYBALVI, COBENFY, Auvelity, BRIXADI, INVEGA SUSTENNA, ARISTADA, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
